by RSM US LLP | Apr 9, 2024
Insights < Back to Insights and Resources Biopharmas: Spending too much on trials, tariffs and indirect taxes?ARTICLE | April 09, 2024Authored by RSM US LLPBiopharmaceutical companies contend with high costs when developing potential drug candidates, managing...
by RSM US LLP | Jan 24, 2024
Insights < Back to Insights and Resources With new regulations, medtech companies should assess cyber riskARTICLE | January 24, 2024Authored by RSM US LLPMedtech companies are increasingly grappling with significant business risks related to the management and...
by RSM US LLP | Jun 23, 2023
Insights < Back to Insights and Resources FDA launches new cybersecurity requirements for medical devicesARTICLE | June 23, 2023Authored by RSM US LLPAs medical device technology has become more advanced and connectivity between a growing number of systems and...
by Vasquez & Company | May 14, 2023
Insights Vasquez Advantage Center Request for Additional Information Thank you for your interest in our Vasquez Advantage Center Services. Please fill out the form below to receive additional information. First Name* Last Name* E-mail* Types of service(s) interested...
by RSM US LLP | Apr 7, 2023
Insights < Back to Insights and Resources Key trends and business considerations for middle market medtech companiesARTICLE | April 07, 2023Authored by RSM US LLPMiddle market medtech companies have been significantly affected by the rise of inflation, market...
Recent Comments